1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Gandara DR, Hammerman PS, Sos ML, Lara PN
Jr and Hirsch FR: Squamous cell lung cancer: From tumor genomics to
cancer therapeutics. Clin Cancer Res. 21:2236–2243. 2015.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Perezmoreno P, Brambilla E, Thomas R and
Soria JC: Squamous cell carcinoma of the lung: Molecular subtypes
and therapeutic opportunities. Clin Cancer Res. 18:2443–2451. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Kuribayashi K, Funaguchi N and Nakano T:
Chemotherapy for advanced non-small cell lung cancer with a focus
on squamous cell carcinoma. J Cancer Res Ther. 12:528–534. 2016.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Morrey ME, Abdel MP, Riester SM, Dudakovic
A, van Wijnen AJ, Morrey BF and Sanchez-Sotelo J: Molecular
landscape of arthrofibrosis: Microarray and bioinformatic analysis
of the temporal expression of 380 genes during contracture genesis.
Gene. 610:15–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Liu C, Fei HD, Sun ZY and Tian JW:
Bioinformatic analysis of the microarray gene expression profile in
degenerative intervertebral disc cells exposed to TNF-α. Eur Rev
Med Pharmacol Sci. 19:3332–3339. 2015.PubMed/NCBI
|
7
|
Meltzer EB, Barry WT, D'Amico TA, Davis
RD, Shu SL, Onaitis MW, Morrison LD, Sporn TA, Steele MP and Noble
PW: Bayesian probit regression model for the diagnosis of pulmonary
fibrosis: Proof-of-principle. BMC Med Genomics. 4:702011.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res 39 (Database Issue).
D991–D1005. 2013.
|
9
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
10
|
Lin J, Marquardt G, Mullapudi N, Wang T,
Han W, Shi M, Keller S, Zhu C, Locker J and Spivack SD: Lung cancer
transcriptomes refined with laser capture microdissection. Am J
Pathol. 184:2868–2884. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Li JR, Sun CH, Li W, Chao RF, Huang CC,
Zhou XJ and Liu CC: Cancer RNA-Seq Nexus: A database of
phenotype-specific transcriptome profiling in cancer cells. Nucleic
Acids Res. 44(D1): D944–D951. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Core Team R: R: A language and environment
for statistical computing. Computing. 1:12–21. 2015.
|
13
|
Troyanskaya O, Cantor M, Sherlock G, Brown
P, Hastie T, Tibshirani R, Botstein D and Altman RB: Missing value
estimation methods for DNA microarrays. Bioinformatics. 17:520–525.
2001. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hogan SJ, Feltz KT, Murdock DR, Goodman
TA, Vercande DJ, Tangeman MR, Busch EM, Kripakaran R, Jayasimha MG,
Smith KE, et al: Call-processing system and method. 2003.
|
15
|
Pathan M, Keerthikumar S, Ang CS, Gangoda
L, Quek CY, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim
A, et al: FunRich: An open access standalone functional enrichment
and interaction network analysis tool. Proteomics. 15:2597–2601.
2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res 38 (Web Server Issue). W214–W220. 2010.
View Article : Google Scholar
|
17
|
Goldman M, Craft B, Zhu J and Haussler D:
Abstract 2584: The UCSC Xena system for cancer genomics data
visualization and interpretation. Cancer Res. 77:25842017.
|
18
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
20
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID gene functional classification tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res 45 (W1).
W98–W102. 2017. View Article : Google Scholar
|
22
|
Piao J, Sun J, Yang Y, Jin T, Chen L and
Lin Z: Target gene screening and evaluation of prognostic values in
non-small cell lung cancers by bioinformatics analysis. Gene.
647:306–311. 2018. View Article : Google Scholar : PubMed/NCBI
|
23
|
Mitteer DR, Greer BD, Fisher WW and Cohrs
VL: Teaching behavior technicians to create publication-quality,
single-case design graphs in graphpad prism 7. J Appl Behav Anal.
51:998–1010. 2018. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Pontén F, Jirström K and Uhlen M: The
human protein atlas-a tool for pathology. J Pathol. 216:387–393.
2010. View Article : Google Scholar
|
25
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Beer DG, Kardia SL, Huang CC, Giordano TJ,
Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al:
Gene-expression profiles predict survival of patients with lung
adenocarcinoma. Nat Med. 8:816–824. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Non-Small Cell Lung Cancer Collaborative
Group, . Chemotherapy and supportive care versus supportive care
alone for advanced non-small cell lung cancer. Cochrane Database
Syst Rev. 12:CD0073092010.
|
28
|
Blandin KS, Crosbie PA, Balata H, Chudziak
J, Hussell T and Dive C: Progress and prospects of early detection
in lung cancer. Open Biol. 7(pii): 1700702017. View Article : Google Scholar : PubMed/NCBI
|
29
|
Mayekar MK and Bivona TG: Current
landscape of targeted therapy in lung cancer. Clin Pharmacol Ther.
102:757–764. 2017. View Article : Google Scholar : PubMed/NCBI
|
30
|
Jamal-Hanjani M, Wilson GA, McGranahan N,
Birkbak NJ, Watkins TBK, Veeriah S, Shafi S, Johnson DH, Mitter R,
Rosenthal R, et al: Tracking the evolution of non-small-cell lung
cancer. N Engl J Med. 376:2109–2121. 2017. View Article : Google Scholar : PubMed/NCBI
|
31
|
Youlden DR, Cramb SM and Baade PD: The
international epidemiology of lung cancer: Geographical
distribution and secular trends. J Thorac Oncol. 3:819–831. 2008.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Cheng TY, Cramb SM, Baade PD, Youlden DR,
Nwogu C and Reid ME: The international epidemiology of lung cancer:
Latest trends, disparities, and tumor characteristics. J Thorac
Oncol. 11:1653–1671. 2016. View Article : Google Scholar : PubMed/NCBI
|
33
|
Raghavachari N: Microarray technology:
Basic methodology and application in clinical research for
biomarker discovery in vascular diseases. Methods Mol Biol.
1027:47–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
34
|
Li G, Li X, Yang M, Xu L, Deng S and Ran
L: Prediction of biomarkers of oral squamous cell carcinoma using
microarray technology. Sci Rep. 7:421052017. View Article : Google Scholar : PubMed/NCBI
|
35
|
Albelda SM and Buck CA: Integrins and
other cell adhesion molecules. FASEB J. 4:2868–2880. 1990.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Zaman MH, Trapani LM, Siemeski A,
Mackellar D, Gong H, Kamm RD, Wells A, Lauffenburger DA and
Matsudaira P: Migration of tumor cells in 3D matrices is governed
by matrix stiffness along with cell-matrix adhesion and
proteolysis. Proc Natl Acad Sci USA. 103:10889–10894. 2006.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Uccelli A, Moretta L and Pistoia V:
Mesenchymal stem cells in health and disease. Nat Rev Immunol.
8:726–736. 2008. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wang D, Song Z and Wang Z: Common
mechanism of pathogenesis in various types of metastatic
osteosarcoma. Oncol Lett. 14:6307–6313. 2017.PubMed/NCBI
|
39
|
Laval S, Laklai H, FanJul M, Pucelle M,
Susini C, Pyronnet S and Bousquet C: Abstract 5181: Forced
hemidesmosome assembly blocks pancreatic cancer cell invasiveness.
Cancer Res. 70:51812011.
|
40
|
Zamanian-Daryoush M and DiDonato JA:
Apolipoprotein A-I and cancer. Front Pharmacol. 6:2652015.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Zhang H, Tao J, Sheng L, Hu X, Rong R, Xu
M and Zhu T: RETRACTED: Twist2 promotes kidney cancer cell
proliferation and invasion via regulating ITGA6 and CD44 expression
in the ECM-Receptor-Interaction pathway. Biomed Biomed
Pharmacother. 81:453–459. 2016. View Article : Google Scholar : PubMed/NCBI
|
42
|
Golubovskaya VM: Focal adhesion kinase as
a cancer therapy target. Anticancer Agents Med Chem. 10:735–741.
2010. View Article : Google Scholar : PubMed/NCBI
|
43
|
Randell SH: Airway epithelial stem cells
and the pathophysiology of chronic obstructive pulmonary disease.
Proc Am Thorac Soc. 3:718–725. 2006. View Article : Google Scholar : PubMed/NCBI
|
44
|
Giangreco A, Reynolds SD and Stripp BR:
Terminal bronchioles harbor a unique airway stem cell population
that localizes to the bronchoalveolar duct junction. Am J Pathol.
161:173–182. 2002. View Article : Google Scholar : PubMed/NCBI
|
45
|
Antico G, Lingen MW, Sassano A, Melby J,
Welch RW, Fiore S, Pilon AL and Miele L: Recombinant human
uteroglobin/CC10 inhibits the adhesion and migration of primary
human endothelial cells via specific and saturable binding to
fibronectin. J Cell Physiol. 207:553–561. 2010. View Article : Google Scholar
|
46
|
Singh G and Katyal SL: Clara cell
proteins. Ann N Y Acad Sci. 923:43–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
47
|
Yang Y, Zhang Z, Mukherjee AB and Linnoila
RI: Increased susceptibility of mice lacking Clara cell 10-kDa
protein to lung tumorigenesis by
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent carcinogen
in cigarette smoke. J Biol Chem. 279:29336–29340. 2004. View Article : Google Scholar : PubMed/NCBI
|
48
|
Wang SZ, Rosenberger CL, Bao YX, Stark JM
and Harrod KS: Clara cell secretory protein modulates lung
inflammatory and immune responses to respiratory syncytial virus
infection. J Immunol. 171:1051–1060. 2003. View Article : Google Scholar : PubMed/NCBI
|
49
|
Watson TM, Reynolds SD, Mango GW, Boe IM,
Lund J and Stripp BR: Altered lung gene expression in CCSP-null
mice suggests immunoregulatory roles for Clara cells. Am J Physiol
Lung Cell Mol Physiol. 281:L1523–L1530. 2001. View Article : Google Scholar : PubMed/NCBI
|
50
|
Laucho-Contreras ME, Polverino F,
Tesfaigzi Y, Pilon A, Celli BR and Owen CA: Club cell protein 16
(CC16) augmentation: A potential disease-modifying approach for
chronic obstructive pulmonary disease (COPD). Expert Opin Ther
Targets. 20:869–883. 2016. View Article : Google Scholar : PubMed/NCBI
|
51
|
Ludovini V, Bianconi F, Siggillino A,
Piobbico D, Vannucci J, Metro G, Chiari R, Bellezza G, Puma F,
Della Fazia MA, et al: Gene identification for risk of relapse in
stage I lung adenocarcinoma patients: A combined methodology of
gene expression profiling and computational gene network analysis.
Oncotarget. 7:30561–30574. 2016. View Article : Google Scholar : PubMed/NCBI
|
52
|
Linnoila RI, Szabo E, DeMayo F, Witschi H,
Sabourin C and Malkinson A: The role of CC10 in pulmonary
carcinogenesis: From a marker to tumor suppression. Ann N Y Acad
Sci. 923:249–267. 2000. View Article : Google Scholar : PubMed/NCBI
|
53
|
Bourdin A, Kotsimbos T, Nguyen K, Vachier
I, Mainprice B, Farce M, Paganin F, Marty-Ané C, Vernhet H, Godard
P and Chanez P: Non-invasive assessment of small airway remodelling
in smokers. COPD. 7:102–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
54
|
Sun Y, Yin X, Wen MM, Zhang J, Wang XJ,
Xia JH, Zhang YN, Zhang ZP and Li XF: EGFR mutations subset in
Chinese lung squamous cell carcinoma patients. Mol Med Rep.
17:7575–7584. 2018.PubMed/NCBI
|
55
|
Thakur C, Rapp UR and Rudel T: Cysts mark
the early stage of metastatic tumor development in non-small cell
lung cancer. Oncotarget. 9:6518–6535. 2017.PubMed/NCBI
|
56
|
Robb L, Mifsud L, Hartley L, Biben C,
Copeland NG, Gilbert DJ, Jenkins NA and Harvey RP: Epicardin: A
novel basic helix-loop-helix transcription factor gene expressed in
epicardium, branchial arch myoblasts, and mesenchyme of developing
lung, gut, kidney, and gonads. Dev Dyn. 213:105–113. 1998.
View Article : Google Scholar : PubMed/NCBI
|
57
|
Smith LT, Lin M, Brena RM, Lang JC,
Schuller DE, Otterson GA, Morrison CD, Smiraglia DJ and Plass C:
Epigenetic regulation of the tumor suppressor gene TCF21 on
6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci USA.
103:982–987. 2006. View Article : Google Scholar : PubMed/NCBI
|
58
|
Arab K, Smith LT, Gast A, Weichenhan D,
Huang JP, Claus R, Hielscher T, Espinosa AV, Ringel MD, Morrison
CD, et al: Epigenetic deregulation of TCF21 inhibits metastasis
suppressor KISS1 in metastatic melanoma. Carcinogenesis.
32:1467–1473. 2011. View Article : Google Scholar : PubMed/NCBI
|
59
|
Costa VL, Henrique R, Danielsen SA, Eknaes
M, Patrício P, Morais A, Oliveira J, Lothe RA, Teixeira MR, Lind GE
and Jerónimo C: TCF21 and PCDH17 methylation: An innovative panel
of biomarkers for a simultaneous detection of urological cancers.
Epigenetics. 6:1120–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
60
|
Richards KL, Zhang B, Sun M, Dong W,
Churchill J, Bachinski LL, Wilson CD, Baggerly KA, Yin G, Hayes DN,
et al: Methylation of the candidate biomarker TCF21 is very
frequent across a spectrum of early-stage nonsmall cell lung
cancers. Cancer. 117:606–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
61
|
Chen X, Kong X, Zhang Z, Chen W, Chen J,
Li H, Cao W, Ge Y and Fang S: Alpha-2-macroglobulin as a
radioprotective agent: A review. Chin J Cancer Res. 26:611–621.
2014.PubMed/NCBI
|
62
|
Kurz S, Thieme R, Amberg R, Groth M,
Jahnke HG, Pieroh P, Horn LC, Kolb M, Huse K, Platzer M, et al:
Correction: The anti-tumorigenic activity of A2M-A lesson from the
naked mole-rat. PLoS One. 13:e01951692018. View Article : Google Scholar : PubMed/NCBI
|
63
|
Birkenmeier G, Müller R, Huse K, Forberg
J, Gläser C, Hedrich H, Nicklisch S and Reichenbach A: Human
alpha2-macroglobulin: Genotype-phenotype relation. Exp Neurol.
184:153–161. 2003. View Article : Google Scholar : PubMed/NCBI
|
64
|
Klaus C, Kaemmerer E, Reinartz A,
Schneider U, Plum P, Jeon MK, Hose J, Hartmann F, Schnölzer M,
Wagner N, et al: TP53 status regulates ACSL5-induced expression of
mitochondrial mortalin in enterocytes and colorectal
adenocarcinomas. Cell Tissue Res. 357:267–278. 2014. View Article : Google Scholar : PubMed/NCBI
|
65
|
Mashima T, Oh-hara T, Sato S, Mochizuki M,
Sugimoto Y, Yamazaki K, Hamada J, Tada M, Moriuchi T, Ishikawa Y,
et al: p53-defective tumors with a functional apoptosome-mediated
pathway: A new therapeutic target. J Natl Cancer Inst. 97:765–777.
2005. View Article : Google Scholar : PubMed/NCBI
|
66
|
Ding S, Tang S, Wang M, Wu D and Guo H:
Acyl-CoA synthetase 5 promotes the growth and invasion of
colorectal cancer cells. Can J Gastroenterol Hepatol.
2017:76157362017. View Article : Google Scholar : PubMed/NCBI
|
67
|
Pitule P, Vycital O, Bruha J, Novak P,
Hosek P, Treska V, Hlavata I, Soucek P, Kralickova M and Liska V:
Differential expression and prognostic role of selected genes in
colorectal cancer patients. Anticancer Res. 33:4855–4865.
2013.PubMed/NCBI
|
68
|
Ni R, Shen X, Wu H, Zhu W, Ni J, Huang Z,
Song Y and Gao X: Expression and significance of integrins subunits
in laryngeal squamous cell carcinoma. Lin Chung Er Bi Yan Hou Tou
Jing Wai Ke Za Zhi. 24:686–689. 2010.(In Chinese). PubMed/NCBI
|
69
|
Xu Z and Wu R: Alteration in metastasis
potential and gene expression in human lung cancer cell lines by
ITGB8 silencing. Anat Rec (Hoboken). 295:1446–1454. 2012.
View Article : Google Scholar : PubMed/NCBI
|
70
|
Huang L, Cai JL, Huang PZ, Kang L, Huang
MJ, Wang L and Wang JP: miR19b-3p promotes the growth and
metastasis of colorectal cancer via directly targeting ITGB8. Am J
Cancer Res. 7:1996–2008. 2017.PubMed/NCBI
|
71
|
Tsubouchi H and Roeder GS: The Mnd1
protein forms a complex with hop2 to promote homologous chromosome
pairing and meiotic double-strand break repair. Mol Cell Biol.
22:3078–3088. 2002. View Article : Google Scholar : PubMed/NCBI
|
72
|
Yeganeh PN, Richardson C,
Bahrani-Mostafavi Z, Tait DL and Mostafavi MT: Dysregulation of
AKT3 along with a small panel of mRNAs stratifies high-grade serous
ovarian cancer from both normal epithelia and benign tumor tissues.
Genes Cancer. 8:784–798. 2017.PubMed/NCBI
|
73
|
Yang Z and Jiang X, Li D, Dong Q, Zhao H
and Jiang X: TCF21 inhibits proliferation and chemoresistance
through the AKT pathway in human gastric cancer. Gene. 682:42–49.
2019. View Article : Google Scholar : PubMed/NCBI
|
74
|
Dai Y, Duan H, Duan C, Zhu H, Zhou R, Pei
H and Shen L: TCF21 functions as a tumor suppressor in colorectal
cancer through inactivation of PI3K/AKT signaling. Onco Targets
Ther. 10:1603–1611. 2017. View Article : Google Scholar : PubMed/NCBI
|
75
|
Shijubo N, Itoh Y and Abe S:
Anti-inflammatory molecule, Clara cell 10 kilodalton protein and
respiratory diseases. Rinsho Byori. 50:370–373. 2002.(In Japanese).
PubMed/NCBI
|
76
|
Joyce JA and Fearon DT: T cell exclusion,
immune privilege, and the tumor microenvironment. Science.
348:74–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
77
|
Kurz S, Thieme R, Amberg R, Groth M,
Jahnke HG, Pieroh P, Horn LC, Kolb M, Huse K, Platzer M, et al: The
anti-tumorigenic activity of A2M-A lesson from the naked mole-rat.
PLoS One. 12:e01895142017. View Article : Google Scholar : PubMed/NCBI
|